Eaton Vance Massachusetts Municipal Bond Fund MAB 深 滬
等待開盤 12-16 09:30:00 美东时间
12.28
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 12.28
- 總市值 2172.00万
- 52周最高 13.4827
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 11.6299
- 委 比 0.00%
- 總股本 176.87万
- 歷史最高 15.2523
- 量 比 0
- 振 幅 0.00%
- 歷史最低 11.6299
- 每 手 1
- 風險率 0.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MAB Academy selects CAE to deliver a new Boeing 737MAX full-flight simulator
KUALA LUMPUR, Malaysia, Oct. 27, 2025 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE announced today the signing of an agreement for the delivery of a state-of-the-art Boeing 737MAX full-flight...
10-27 18:00
山东省青岛市市场监督管理局公布15批次运动服装产品监督抽查结果
中国质量新闻网讯 近日，山东省青岛市市场监督管理局公布2025年第3批工业产品质量日常监督抽查结果。其中，抽查15批次运动服装产品，生产领域4批次、流通领域1...
10-20 15:11
Soligenix Updates U.S. Medical Advisory Board To Guide Phase 3 HyBryte Development For CTCL
Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical DevelopmentPRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage
10-14 19:33
Soligenix Expands European MAB To Provide Addl Medical/Clinical Strategic Guidance As It Advances Confirmatory Phase 3 Placebo-Controlled Study Evaluating Safety And Efficacy Of HyBryte In CTCL Treatment
In preparation for health authority interactions in pursuit of marketing approvals in Europe PRINCETON, N.J., Sept. 30, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a
09-30 19:36
Mortgage Advice Bureau Directors Increase Shareholdings
Mortgage Advice Bureau (Holdings) ( ($GB:MAB1) ) just unveiled an announcement....
09-25 23:32
Mitchells & Butlers to Release Pre-Close Trading Statement
Mitchells & Butlers ( ($GB:MAB) ) just unveiled an announcement. Mitchells ...
09-23 19:32
微算法科技（NASDAQ:MLGO）多注意力循环网络：MARN技术如何让机器理解语言、手势与语音的微妙交互
在信息技术快速发展的今天，人工智能（AI）不断挑战人类交流的复杂性，尤其是面对面交流。人类使用语言、视觉手势和声学语调等多种模态进行沟通，而人工智能如何理解这些...
09-23 10:15
Alvotech's Commercialization Partner In Japan, Fuji Pharma, Receives Marketing Approval For Three New Biosimilars From Japanese Ministry Of Health, Labor And Welfare
Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in Japan, Fuji Pharma
09-19 19:47
山东省市场监督管理局公布2025年电动汽车充电桩产品质量省级监督抽查结果
中国质量新闻网讯 近日，山东省市场监督管理局公布2025年电动汽车充电桩产品质量省级监督抽查结果。2025年第2批产品质量省级监督抽查共抽查生产环节电动汽车充电...
09-16 14:10
Mitchells & Butlers Directors Acquire Partnership Shares
Mitchells & Butlers ( ($GB:MAB) ) just unveiled an update. Mitchells & ...
09-15 19:02
公司簡介
公司名稱
|
Eaton Vance Massachusetts Municipal Bond Fund
|
行業分類
|
--
|
業務描述
|
Eaton Vance Massachusetts Municipal Bond Fund operates as a closed-end investment fund. Its investment objective is to provide current income exempt from federal income tax, including alternative minimum tax, and in the form of an investment exempt from Massachusetts personal income tax. The company was founded on November 29, 2002 and is headquartered in Boston, MA.
|
MAB Academy selects CAE to deliver a new Boeing 737MAX full-flight simulator
KUALA LUMPUR, Malaysia, Oct. 27, 2025 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE announced today the signing of an agreement for the delivery of a state-of-the-art Boeing 737MAX full-flight...
10-27 18:00
山东省青岛市市场监督管理局公布15批次运动服装产品监督抽查结果
中国质量新闻网讯 近日，山东省青岛市市场监督管理局公布2025年第3批工业产品质量日常监督抽查结果。其中，抽查15批次运动服装产品，生产领域4批次、流通领域1...
10-20 15:11
Soligenix Updates U.S. Medical Advisory Board To Guide Phase 3 HyBryte Development For CTCL
Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical DevelopmentPRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage
10-14 19:33
Soligenix Expands European MAB To Provide Addl Medical/Clinical Strategic Guidance As It Advances Confirmatory Phase 3 Placebo-Controlled Study Evaluating Safety And Efficacy Of HyBryte In CTCL Treatment
In preparation for health authority interactions in pursuit of marketing approvals in Europe PRINCETON, N.J., Sept. 30, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a
09-30 19:36
Mortgage Advice Bureau Directors Increase Shareholdings
Mortgage Advice Bureau (Holdings) ( ($GB:MAB1) ) just unveiled an announcement....
09-25 23:32
Mitchells & Butlers to Release Pre-Close Trading Statement
Mitchells & Butlers ( ($GB:MAB) ) just unveiled an announcement. Mitchells ...
09-23 19:32
微算法科技（NASDAQ:MLGO）多注意力循环网络：MARN技术如何让机器理解语言、手势与语音的微妙交互
在信息技术快速发展的今天，人工智能（AI）不断挑战人类交流的复杂性，尤其是面对面交流。人类使用语言、视觉手势和声学语调等多种模态进行沟通，而人工智能如何理解这些...
09-23 10:15
Alvotech's Commercialization Partner In Japan, Fuji Pharma, Receives Marketing Approval For Three New Biosimilars From Japanese Ministry Of Health, Labor And Welfare
Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in Japan, Fuji Pharma
09-19 19:47
山东省市场监督管理局公布2025年电动汽车充电桩产品质量省级监督抽查结果
中国质量新闻网讯 近日，山东省市场监督管理局公布2025年电动汽车充电桩产品质量省级监督抽查结果。2025年第2批产品质量省级监督抽查共抽查生产环节电动汽车充电...
09-16 14:10
Mitchells & Butlers Directors Acquire Partnership Shares
Mitchells & Butlers ( ($GB:MAB) ) just unveiled an update. Mitchells & ...
09-15 19:02
派息除權日
|
每股總股息
| 派息日期 |
2018-12-12
|
0.05
|
2018-12-31
|
2018-11-21
|
0.04
|
2018-11-30
|
2018-10-23
|
0.04
|
2018-10-31
|
2018-09-20
|
0.04
|
2018-09-28
|
2018-08-23
|
0.04
|
2018-08-31
|
2018-07-23
|
0.04
|
2018-07-31
|
2018-06-21
|
0.04
|
2018-06-29
|
2018-05-23
|
0.04
|
2018-05-31
|
2018-04-20
|
0.04
|
2018-04-30
|
2018-03-21
|
0.04
|
2018-03-29
|
2018-02-20
|
0.04
|
2018-02-28
|
2018-01-23
|
0.04
|
2018-01-31
|
2017-12-21
|
0.04
|
2017-12-29
|
2017-11-21
|
0.04
|
2017-11-30
|
2017-10-23
|
0.04
|
2017-10-31
|
2017-09-21
|
0.04
|
2017-09-29
|
2017-08-22
|
0.04
|
2017-08-31
|
2017-07-20
|
0.04
|
2017-07-31
|
2017-06-21
|
0.04
|
2017-06-30
|
2017-05-22
|
0.04
|
2017-05-31
|
2017-04-19
|
0.05
|
2017-04-28
|
2017-03-22
|
0.05
|
2017-03-31
|
2017-02-16
|
0.05
|
2017-02-28
|
2017-01-20
|
0.05
|
2017-01-31
|
2016-12-21
|
0.05
|
2016-12-30
|
2016-11-21
|
0.05
|
2016-11-30
|
2016-10-20
|
0.05
|
2016-10-31
|
2016-09-21
|
0.05
|
2016-09-30
|
2016-08-22
|
0.05
|
2016-08-31
|
2016-07-20
|
0.05
|
2016-07-29
|
2016-06-21
|
0.05
|
2016-06-30
|
2016-05-20
|
0.05
|
2016-05-31
|
2016-04-20
|
0.05
|
2016-04-29
|
2016-03-22
|
0.05
|
2016-03-31
|
2016-02-18
|
0.05
|
2016-02-29
|
2016-01-20
|
0.05
|
2016-01-29
|
2015-12-21
|
0.06
|
2015-12-30
|
2015-11-19
|
0.06
|
2015-11-30
|
2015-10-21
|
0.06
|
2015-10-30
|
2015-09-21
|
0.06
|
2015-09-30
|
2015-08-20
|
0.06
|
2015-08-31
|
2015-07-22
|
0.06
|
2015-07-31
|
2015-06-19
|
0.06
|
2015-06-30
|
2015-05-20
|
0.06
|
2015-05-29
|
2015-04-21
|
0.06
|
2015-04-30
|
2015-03-20
|
0.06
|
2015-03-31
|
2015-02-18
|
0.06
|
2015-02-27
|
2015-01-21
|
0.06
|
2015-01-30
|
2014-12-22
|
0.06
|
2014-12-31
|
2014-11-19
|
0.06
|
2014-11-28
|
2014-10-22
|
0.06
|
2014-10-31
|
2014-09-19
|
0.06
|
2014-09-30
|
2014-08-20
|
0.06
|
2014-08-29
|
2014-07-22
|
0.06
|
2014-07-31
|
2014-06-19
|
0.06
|
2014-06-30
|
2014-05-21
|
0.06
|
2014-05-30
|
2014-04-21
|
0.06
|
2014-04-30
|
2014-03-20
|
0.06
|
2014-03-31
|
2014-02-19
|
0.06
|
2014-02-28
|
2014-01-22
|
0.06
|
2014-01-31
|
2013-12-20
|
0.06
|
2013-12-31
|
2013-11-20
|
0.06
|
2013-11-29
|
2013-10-22
|
0.06
|
2013-10-31
|
2013-09-19
|
0.06
|
2013-09-30
|
2013-08-21
|
0.06
|
2013-08-30
|
2013-07-22
|
0.06
|
2013-07-31
|
2013-06-19
|
0.06
|
2013-06-28
|
2013-05-22
|
0.06
|
2013-05-31
|
2013-04-19
|
0.06
|
2013-04-30
|
2013-03-19
|
0.06
|
2013-03-28
|
2013-02-19
|
0.06
|
2013-02-28
|
2013-01-22
|
0.07
|
2013-01-31
|
2012-12-20
|
0.07
|
2012-12-31
|
2012-11-20
|
0.07
|
2012-11-30
|
2012-10-22
|
0.07
|
2012-10-31
|
2012-09-19
|
0.07
|
2012-09-28
|
2012-08-22
|
0.07
|
2012-08-31
|
2012-07-20
|
0.07
|
2012-07-31
|
2012-06-20
|
0.07
|
2012-06-29
|
2012-05-22
|
0.07
|
2012-05-31
|
2012-04-19
|
0.07
|
2012-04-30
|
2012-03-21
|
0.07
|
2012-03-30
|
2012-02-17
|
0.07
|
2012-02-29
|
2012-01-20
|
0.07
|
2012-01-31
|
2011-12-21
|
0.07
|
2011-12-30
|
2011-11-21
|
0.07
|
2011-11-30
|
2011-10-20
|
0.07
|
2011-10-31
|
2011-09-21
|
0.07
|
2011-09-30
|
2011-08-22
|
0.07
|
2011-08-31
|
2011-07-20
|
0.07
|
2011-07-29
|
2011-06-21
|
0.07
|
2011-06-30
|
2011-05-20
|
0.07
|
2011-05-31
|
2011-04-19
|
0.07
|
2011-04-29
|
2011-03-22
|
0.07
|
2011-03-31
|
2011-02-16
|
0.07
|
2011-02-28
|
2011-01-20
|
0.07
|
2011-01-31
|
2010-12-21
|
0.07
|
2010-12-31
|
2010-11-19
|
0.07
|
2010-11-30
|
2010-10-20
|
0.07
|
2010-10-29
|
2010-09-21
|
0.07
|
2010-09-30
|
2010-08-20
|
0.07
|
2010-08-31
|
2010-07-21
|
0.07
|
2010-07-30
|
2010-06-21
|
0.07
|
2010-06-30
|
2010-05-19
|
0.07
|
2010-05-28
|
2010-04-21
|
0.07
|
2010-04-30
|
2010-03-22
|
0.07
|
2010-03-31
|
2010-02-17
|
0.07
|
2010-02-26
|
2010-01-20
|
0.07
|
2010-01-29
|
2009-12-22
|
0.07
|
2009-12-31
|
2009-11-19
|
0.07
|
2009-11-30
|
2009-10-21
|
0.07
|
2009-10-30
|
2009-09-21
|
0.07
|
2009-09-30
|
2009-08-20
|
0.07
|
2009-08-31
|
2009-07-22
|
0.07
|
2009-07-31
|
2009-06-19
|
0.07
|
2009-06-30
|
2009-05-20
|
0.07
|
2009-05-29
|
2009-04-21
|
0.07
|
2009-04-30
|
2009-03-20
|
0.06
|
2009-03-31
|
2009-02-18
|
0.06
|
2009-02-27
|
2009-01-21
|
0.06
|
2009-01-30
|
2008-12-22
|
0.06
|
2008-12-31
|
2008-11-19
|
0.06
|
2008-11-28
|
2008-10-22
|
0.06
|
2008-10-31
|
2008-09-19
|
0.06
|
2008-09-30
|
2008-08-20
|
0.06
|
2008-08-29
|
2008-07-22
|
0.06
|
2008-07-31
|
2008-06-19
|
0.06
|
2008-06-30
|
2008-05-13
|
0.06
|
2008-05-22
|
2008-04-21
|
0.06
|
2008-04-30
|
2008-03-19
|
0.06
|
2008-03-31
|
2008-02-20
|
0.06
|
2008-02-29
|
2008-01-22
|
0.06
|
2008-01-31
|
2007-12-19
|
0.06
|
2007-12-28
|
2007-11-20
|
0.06
|
2007-11-30
|
2007-10-22
|
0.06
|
2007-10-31
|
2007-09-19
|
0.06
|
2007-09-28
|
2007-08-22
|
0.06
|
2007-08-31
|
2007-07-20
|
0.06
|
2007-07-31
|
2007-06-20
|
0.06
|
2007-06-29
|
2007-05-22
|
0.06
|
2007-05-31
|
2007-04-19
|
0.06
|
2007-04-30
|
2007-03-21
|
0.06
|
2007-03-30
|
2007-02-16
|
0.06
|
2007-02-28
|
2007-01-22
|
0.06
|
2007-01-31
|
2006-12-19
|
0.06
|
2006-12-28
|
2006-11-20
|
0.06
|
2006-11-30
|
2006-10-20
|
0.06
|
2006-10-31
|
2006-09-20
|
0.06
|
2006-09-29
|
2006-08-22
|
0.06
|
2006-08-31
|
2006-07-20
|
0.06
|
2006-07-31
|
2006-06-21
|
0.06
|
2006-06-30
|
2006-05-22
|
0.06
|
2006-05-31
|
2006-04-19
|
0.06
|
2006-04-28
|
2006-03-22
|
0.06
|
2006-03-31
|
2006-02-16
|
0.06
|
2006-02-28
|
2006-01-20
|
0.06
|
2006-01-31
|
2005-12-20
|
0.08
|
2005-12-29
|
2005-11-21
|
0.08
|
2005-11-30
|
2005-10-20
|
0.08
|
2005-10-31
|
2005-09-21
|
0.08
|
2005-09-30
|
2005-08-22
|
0.08
|
2005-08-31
|
2005-07-20
|
0.08
|
2005-07-29
|
2005-06-21
|
0.08
|
2005-06-30
|
2005-05-19
|
0.08
|
2005-05-31
|
2005-04-20
|
0.08
|
2005-04-29
|
2005-03-22
|
0.08
|
2005-03-31
|
2005-02-17
|
0.08
|
2005-02-28
|
2005-01-20
|
0.08
|
2005-01-31
|
2004-12-21
|
0.08
|
2004-12-30
|
2004-11-22
|
0.08
|
2004-11-30
|
2004-10-21
|
0.08
|
2004-10-29
|
2004-09-22
|
0.08
|
2004-09-30
|
2004-08-23
|
0.08
|
2004-08-31
|
2004-07-22
|
0.08
|
2004-07-30
|
2004-06-22
|
0.08
|
2004-06-30
|
2004-05-20
|
0.08
|
2004-05-28
|
2004-04-22
|
0.08
|
2004-04-30
|
2004-03-22
|
0.08
|
2004-03-31
|
2004-02-19
|
0.08
|
2004-02-27
|
2004-01-22
|
0.08
|
2004-01-30
|
2003-12-23
|
0.22
|
2003-12-31
|
2003-12-22
|
0.08
|
2003-12-30
|
2003-11-20
|
0.08
|
2003-12-01
|
2003-10-22
|
0.08
|
2003-10-31
|
2003-09-22
|
0.08
|
2003-09-30
|
2003-08-21
|
0.08
|
2003-08-29
|
2003-07-22
|
0.08
|
2003-07-31
|
2003-06-19
|
0.08
|
2003-06-30
|
2003-05-21
|
0.08
|
2003-05-30
|
2003-04-22
|
0.08
|
2003-04-30
|
2003-03-20
|
0.08
|
2003-03-31
|
2003-02-20
|
0.08
|
2003-03-03
|
2003-01-23
|
0.08
|
2003-01-31
|
